Berberine has an insulin sensitizing effect
Benefits of AOD 9604 Feb 10, 2022 AOD 9604 is FDA approved and often marketed as an anti-obesity drug
DOI: Published online: February 24, 2023 1 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea 2 Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA Corresponding authors: Young Min Cho Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: [email protected] Changhan Lee Leonard Davis School of Gerontology, University of Southern California, 3715 McClintock Ave, Los Angeles, CA 90089, USA E-mail: [email protected] Copyright 2023 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
Mounjaro and other GLP-1-based medicines can also cause nausea, vomiting, diarrhoea, constipation and abdominal discomfort
The other thing is that patients with diabetes may have autonomic dysfunction that's a known complication of diabetes, so they don't regulate blood pressure well
C
